Clinical Trial Update: A Phase 1 Trial of Intrathecal Rituximab for Progressive Multiple Sclerosis Patients [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial evaluating intrathecal rituximab in patients with progressive multiple sclerosis (primary and secondary).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Johns Hopkins University | Conditions: Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis | Phase 1 | Status: COMPLETED